Deanna L. Kelly, PharmD, BCPP

JCP
Consensus Statement

May 19, 2020

The quantification of antipsychotic levels in blood, or therapeutic drug monitoring (TDM), could aid clinicians in numerous challenging scenarios. Learn more about using TDM for dosing decisions in this...
Georgios Schoretsanitis, John M. Kane, Christoph U. Correll, et al
JCP
Original Research

November 23, 2016

Is clozapine safe for patients with benign neutropenia? Many patients with lower than normal absolute neutrophil count do not qualify for clozapine therapy or are at risk of having...
Charles M. Richardson, Erica A. Davis, Gopal R. Vyas, et al
PCC
Letter to the Editor

September 1, 2016

Cannabis withdrawal symptoms are clinically significant because they may act as negative reinforcement for relapse to cannabis use. Here, the authors present data on psychoactive substance use before and...
Maju Mathew Koola, Deanna L. Kelly, Robert P. McMahon, et al
JCP
Original Research

January 12, 2010

Deanna L. Kelly, Robert P. McMahon, Fang Liu, et al
JCP
Original Research

April 7, 2009

Deanna L. Kelly, Robert W. Buchanan, Douglas L. Boggs, et al
JCP
Original Research

September 15, 2006

Deanna L. Kelly, Lisa B. Dixon, Julie A. Kreyenbuhl, et al
JCP
Original Research

September 15, 2006

Do-Un Jung, Robert R. Conley, Deanna L. Kelly, et al
JCP
Original Research

January 15, 2005

Deanna L. Kelly, Robert R. Conley
JCP
Letter to the Editor

September 1, 2003

Deanna L. Kelly, Julie Kreyenbuhl, Raymond C. Love, et al
JCP
Original Research

November 30, 1999

Raymond C. Love, Robert R. Conley, Deanna L. Kelly, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe